EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

Martin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede iD, Eva Maria Schleicher, Liv Grete Ahl, Lea Wagner, Falko Zucker-Reimann, Hannah Rieland, Jim Benjamin Mauz, Julia Weinmann-Menke, Bernhard C Meyer, Michael Bernhard Pitton und 5 weitere

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70315 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2026. Verfasst von Martin Andreas Kabelitz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department for Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Frailty, Liver Cirrhosis, Portasystemic Shunt, Transjugular Intrahepatic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung, Dr. Rolf M. Schwiete Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Frailty is associated with a poorer prognosis of patients awaiting liver transplantation. Data on the impact of frailty on prognosis after transjugular intrahepatic portosystemic shunt (TIPS)‐insertion in patients with cirrhosis and the influence of TIPS on longitudinal changes in frailty are lacking.

Methods

We retrospectively analysed data of 123 prospectively recruited patients with cirrhosis in Mainz and Hannover prior to elective TIPS insertion and monitored them for death/liver transplantation or post‐TIPS overt hepatic encephalopathy (OHE). Patients underwent testing with the Liver Frailty Index (LFI) prior to TIPS insertion as well as 1, 3 and 6 months after TIPS placement.

Results

Median LFI prior to TIPS insertion was 4.32 (interquartile range: 3.78–4.88). 53% of patients who were frail at baseline and still alive at 6 months improved to prefrail status within 6 months of TIPS insertion. Higher LFI and younger age were associated with a decrease in LFI within 6 months. During follow‐up, 40 patients developed post‐TIPS OHE and 30 patients died or received a liver transplantation. There was no significant association between LFI as a metric variable and post‐TIPS OHE or liver transplantation/death. However, patients with LFI values in the lowest quartile had a significantly better transplantation‐free survival.

Conclusions

TIPS insertion seems to improve physical functioning, as indicated by a decreasing LFI, but only in patients with a poor performance in LFI prior to TIPS. Conducting LFI prior to elective TIPS insertion can identify those with an excellent prognosis. However, frailty should not be considered a contraindication for TIPS. Trial Registration ClinicalTrials.gov identifier: NCT05466669 and NCT04801290

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyLiver CirrhosisPortasystemic Shunt, Transjugular IntrahepaticAgedFemaleHumansMaleMiddle AgedHepatic EncephalopathyLiver TransplantationPrognosisRetrospective Studies

Stichwörter der Autor:innen

TIPSfrailtyhepatic encephalopathyliver cirrhosistransjugular intrahepatic portosystemic shunt

Autor:innen und Institutionen

  • Department for Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Cirrhosis Center Mainz (CCM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • German Center for Infectious Research, Partner Site Hannover-Braunschweig, Braunschweig, Germany.
  • Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Anja Tiede, Heiner Wedemeyer, Lisa Sandmann, Benjamin Maasoumy, Christian Labenz

Förderung

  • Deutsches Zentrum für Infektionsforschung
  • Dr. Rolf M. Schwiete Stiftung

Zitieren

APA

Kabelitz, M. A., Gairing, S. J., Tiede, A., Schleicher, E. M., Ahl, L. G., Wagner, L., Zucker-Reimann, F., Rieland, H., Mauz, J. B., Weinmann-Menke, J., Meyer, B. C., Pitton, M. B., Wedemeyer, H., Galle, P. R., Sandmann, L., Maasoumy, B., & Labenz, C. (2026). Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70315

Vancouver

Kabelitz MA, Gairing SJ, Tiede A, Schleicher EM, Ahl LG, Wagner L, et al. Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70315

BibTeX
@article{Kabelitz2026,
  author = {Kabelitz, Martin Andreas and Gairing, Simon Johannes and Tiede, Anja and Schleicher, Eva Maria and Ahl, Liv Grete and Wagner, Lea and Zucker-Reimann, Falko and Rieland, Hannah and Mauz, Jim Benjamin and Weinmann-Menke, Julia and Meyer, Bernhard C and Pitton, Michael Bernhard and Wedemeyer, Heiner and Galle, Peter Robert and Sandmann, Lisa and Maasoumy, Benjamin and Labenz, Christian},
  title = {Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70315}
}
Kostenlos starten →